Table 1 Countries in the APMEN region and their recommendation in regards to vivax treatment and G6PD testing prior to PQ administration, based on WHO’s World Malaria Report, 2016 [9]
Country | Current treatment recommendation for P. vivax | Year PQ adopted | G6PD testing recommended in guidelines | Year policy on G6PD testing adopted |
|---|---|---|---|---|
Bangladesh | CQ + PQ (14 days at 0.25 mg/kg) | 2008 | No | |
Bhutan | CQ + PQ (14 days at 0.25 mg/kg) | Unknown | No | |
Cambodia | DHA-PPQ + PQ (14 days at 0.25 mg/kg) | 2013 | Yes | 2012 |
China | CQ + PQ (8 days at 0.75 mg/kg) | 1970 | No | |
Democratic People’s Republic of Korea | CQ + PQ (14 days at 0.25 mg/kg) | 2000 | No | |
India | CQ + PQ (14 days at 0.25 mg/kg) | 1982 | No | |
Indonesia | DHA-PPQ + PQ (14 days at 0.25 mg/kg) | 2004 | No | |
Lao People’s Democratic Republic | CQ + PQ (14 days at 0.25 mg/kg) | Unknowna | Yes | 2010 |
Malaysia | CQ + PQ (14 days at 0.5 mg/kg) | 1993 | Yes | 1993 |
Myanmar | CQ + PQ (14 days at 0.25 mg/kg) | 1951 | No | |
Nepal | CQ + PQ (14 days at 0.25 mg/kg) | 2009 | Yes | Unknown |
Papua New Guinea | AL + PQ (14 days at 0.25 mg/kg) | 2009 | No | |
Philippines | CQ + PQ (14 days) | 2002 or 2007b | Yes | 2009 |
Republic of Korea | CQ + PQ (14 days at 0.25 mg/kg) | 2001 | No | |
Solomon Islands | AL + PQ (14 days at 0.25 mg/kg) | 2009 | Yes | 2009 |
Sri Lankac | CQ + PQ (14 days at 0.25 mg/kg) | Unknown | Yes | Unknown |
Thailand | CQ + PQ (14 days at 0.25 mg/kg) | 1965 | Yes | 2015 |
Timor-Leste | CQ + PQ (14 days at 0.5 mg/kg) | 2006 | No | |
Vanuatu | AL + PQ (14 days at 0.25 mg/kg) | 2009 | Yes | 2009 |
Vietnam | CQ + PQ (14 days at 0.25 mg/kg) | 1960 | No |